You just read:

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

News provided by

Boston Scientific Corporation

Sep 25, 2010, 11:34 ET